Almost 90 years after its foundation, the Italian Biochemical Institute has implemented a strategy of growth for the next years and has renewed its efforts to compete on an international level.

The head of the Ibi group, IBIGEN, has entered a joint venture with an international group, giving birth to a new company called , Ibi’s quality service, entirely dedicated to the hospital channel.

Ibi has developed a new distribution strategy to hospitals, entrusting sales of its products to a new dedicated company, , fruit of a joint venture and present today in the UK, Germany and Italy.